返回 $name
Session Chair(s)
Jake Doran
Head of Digital
Lykos Therapeutics, United States
Learning Objective : 1. Identify challenges in collecting and managing high-quality regulatory information 2. Compare and contrast with best practices in other verticals such as banking and financial sectors 3. Highlight considerations to treat regulatory information as a corporate asset
Speaker(s)
Regulatory Information: (Un)necessary Evil or Corporate Asset?
Venkatraman Balasubramanian, PhD, MBA
Orion Innovation, United States
SVP and Global Head, Industry Solutions - Healthcare and Life Sciences
Digital Health Impact on Regulatory and RIM
Michael Sauter
United States
Senior Director, Global Regulatory Operations
Achieving a Future State RIM Solution
John Jones
Independent Contractor, United States